AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24219768 — intervention group
Group type: EXPERIMENTAL
Intervention: Illness Management and Recovery (IMR) intervention delivered by mental health professionals (n=126)
Number of subjects: 252
Study 24219768 — intervention group
Group type: EXPERIMENTAL
Intervention: Illness Management and Recovery (IMR) intervention delivered by peer providers (n=43)
Number of subjects: 252
Study 24219768 — intervention group
Group type: EXPERIMENTAL
Intervention: Illness Management and Recovery (IMR) intervention delivered by paraprofessionals (n=41)
Number of subjects: 252
Study 24219768 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU; n=42)
Number of subjects: 252
Study 21603894 — intervention group
Group type: EXPERIMENTAL
Intervention: Restraint group
Number of subjects: 90
Study 21603894 — intervention group
Group type: EXPERIMENTAL
Intervention: Disinhibition group
Number of subjects: 90
Study 21603894 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 19626559 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based medicine (EBM) interventions in brain injury rehabilitation
Number of subjects: 0
Study 19626559 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised controlled trial (RCT) methodology
Number of subjects: 0
Study 19626559 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions in brain injury rehabilitation
Number of subjects: 0
Study 19626559 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethical practice in brain injury rehabilitation
Number of subjects: 0
Study 16490894 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthesia with monitored anesthesia care (MAC)
Number of subjects: 58
Study 16490894 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 58
Study 16490894 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthesia with MAC
Number of subjects: 58
Study 15103454 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip protectors (n=276)
Number of subjects: 561
Study 15103454 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=285)
Number of subjects: 561
Study 11194529 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofu diet (290 grams per day)
Number of subjects: 42
Study 11194529 — intervention group
Group type: COMPARATOR
Intervention: Meat diet (150 grams per day)
Number of subjects: 42
Study 9051538 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA removal during anesthesia (before airway reflexes return)
Number of subjects: 333
Study 9051538 — intervention group
Group type: COMPARATOR
Intervention: LMA removal after return of airway reflexes
Number of subjects: 333
Study 8395315 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine, 150 mg in the morning and at bedtime
Number of subjects: 90
Study 8395315 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibacterial drugs (gentamicin, terramycin, furazolidone, berberine)
Number of subjects: 90
Study 2439568 — intervention group
Group type: EXPERIMENTAL
Intervention: ARA-AMP 10 mg/kg/day for 5 days followed by 5 mg/kg/day for 23 days (15 patients)
Number of subjects: 29
Study 2439568 — intervention group
Group type: COMPARATOR
Intervention: No treatment (14 patients)
Number of subjects: 29
Study 29751239 — intervention group
Group type: EXPERIMENTAL
Intervention: Deprexis (12-week psychological online intervention)
Number of subjects: 577
Study 29751239 — intervention group
Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 577
Study 28254962 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketamine (up to 2 mg/kg)
Number of subjects: 0
Study 28254962 — intervention group
Group type: COMPARATOR
Intervention: Intravenous propofol (up to 2.5 mg/kg)
Number of subjects: 0
Study 25617503 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 20 mg/kg/day
Number of subjects: 40
Study 23758305 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided three-in-one femoral nerve block plus morphine (FNB group)
Number of subjects: 36
Study 23758305 — intervention group
Group type: COMPARATOR
Intervention: Standard care (placebo plus morphine) (SC group)
Number of subjects: 36
Study 19304860 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion
Number of subjects: 0
Study 19304860 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 0
Study 18928094 — intervention group
Group type: EXPERIMENTAL
Intervention: Danhong Injection (DHI) 1.5 mL/kg
Number of subjects: 50
Study 18928094 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 50
Study 18928094 — intervention group
Group type: EXPERIMENTAL
Intervention: Danhong Injection (DHI)
Number of subjects: 50
Study 16382131 — intervention group
Group type: EXPERIMENTAL
Intervention: Tdap vaccine (single dose)
Number of subjects: 0
Study 16382131 — intervention group
Group type: EXPERIMENTAL
Intervention: Tdap and MCV4 vaccines
Number of subjects: 0
Study 16382131 — intervention group
Group type: EXPERIMENTAL
Intervention: Tdap vaccine
Number of subjects: 0
Study 16382131 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal Tdap immunization
Number of subjects: 0
Study 11980744 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg pethidine and 25 mg promethazine (premedication group)
Number of subjects: 100
Study 11980744 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo group)
Number of subjects: 100
Study 9796890 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital imaging
Number of subjects: 4286
Study 9796890 — intervention group
Group type: COMPARATOR
Intervention: Optometrist reports
Number of subjects: 4286
Study 9796890 — intervention group
Group type: COMPARATOR
Intervention: Ophthalmologist slit‐lamp examination
Number of subjects: 4286
Study 8547558 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1: Immediate extubation after reversal of neuromuscular blockade with neostigmine and atropine.
Number of subjects: 100
Study 8547558 — intervention group
Group type: COMPARATOR
Intervention: Group 2: Elective ventilation for an average duration of 5 hours and 29 minutes post-surgery.
Number of subjects: 100
Study 8547558 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypercarbia induced in patients ventilated post-surgery (PaCO2 51.5 ± 3.7 mmHg).
Number of subjects: 100
Study 8547558 — intervention group
Group type: EXPERIMENTAL
Intervention: Restoration of normocarbia (PaCO2 40 ± 2.5 mmHg).
Number of subjects: 100
Study 8547558 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous monitoring of end-tidal CO2 and frequent blood gas analyses.
Number of subjects: 100
Study 2226884 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemolite device (salvage autotransfusion)
Number of subjects: 67
Study 2226884 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cell saver)
Number of subjects: 67
Study 213837 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline alone
Number of subjects: 100
Study 213837 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroergotamin (DHE) alone
Number of subjects: 100
Study 213837 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of amitriptyline and DHE
Number of subjects: 100
Study 213837 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroergotamin (DHE) added to amitriptyline
Number of subjects: 100
Study 30845038 — intervention group
Group type: COMPARATOR
Intervention: Group A: single dose of 2.0 g of TXA orally at 2 hours preoperatively
Number of subjects: 200
Study 30845038 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: 2.0 g of TXA orally at 2 hours preoperatively + 1.0 g at 3 hours postoperatively
Number of subjects: 200
Study 30845038 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C: 2.0 g of TXA orally at 2 hours preoperatively + 1.0 g at 3 and 9 hours postoperatively
Number of subjects: 200
Study 30845038 — intervention group
Group type: EXPERIMENTAL
Intervention: Group D: 2.0 g of TXA orally at 2 hours preoperatively + 1.0 g at 3, 9, and 15 hours postoperatively
Number of subjects: 200
Study 29924009 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT + endostar
Number of subjects: 23
Study 29924009 — intervention group
Group type: COMPARATOR
Intervention: IMRT + chemotherapy
Number of subjects: 23
Study 27858874 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS stimulation of right secondary somatosensory cortex (S2)
Number of subjects: 16
Study 27858874 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS stimulation of primary somatosensory cortex (S1) and primary motor cortex (M1)
Number of subjects: 16
Study 27858874 — intervention group
Group type: COMPARATOR
Intervention: Placebo rTMS treatments
Number of subjects: 16
Study 24854296 — intervention group
Group type: EXPERIMENTAL
Intervention: 2MD (2‐methylene‐19‐nor‐(20S)‐1α,25‐dihydroxyvitamin D3) at 2.5 ng/bw/day in uremic rats
Number of subjects: 2
Study 24854296 — intervention group
Group type: EXPERIMENTAL
Intervention: 2MD (2‐methylene‐19‐nor‐(20S)‐1α,25‐dihydroxyvitamin D3) after 3 daily oral doses for 4 weeks in postmenopausal women
Number of subjects: 2
Study 21607928 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof IQ ReSTOR SN6AD3 IOL
Number of subjects: 36
Study 21607928 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof IQ ReSTOR SN6AD1 IOL
Number of subjects: 36
Study 21607928 — intervention group
Group type: COMPARATOR
Intervention: AcrySof IQ SN60WF (Control)
Number of subjects: 36
Study 21138217 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous Blood Transfusion (ABT) drain
Number of subjects: 168
Study 21138217 — intervention group
Group type: COMPARATOR
Intervention: Suction drain
Number of subjects: 168
Study 21138217 — intervention group
Group type: COMPARATOR
Intervention: No drain
Number of subjects: 168
Study 17427529 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanate
Number of subjects: 225
Study 17427529 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 225
Study 17427529 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 225
Study 17427529 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall antibiotics
Number of subjects: 225
Study 15928613 — intervention group
Group type: EXPERIMENTAL
Intervention: Studies with at least one author with a reported conflict of interest
Number of subjects: 179
Study 15928613 — intervention group
Group type: COMPARATOR
Intervention: Studies without reported conflicts of interest
Number of subjects: 179
Study 12216558 — intervention group
Group type: EXPERIMENTAL
Intervention: Low‐shrinking resin composite
Number of subjects: 49
Study 12216558 — intervention group
Group type: COMPARATOR
Intervention: Amalgam
Number of subjects: 49
Study 9466046 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography reminder letter
Number of subjects: 202
Study 8527277 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin infusion at a dose of 6 mg kg‐1 for 30 min
Number of subjects: 11
Study 8527277 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin in CAVH patients
Number of subjects: 11
Study 2093020 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole, 40 mg once daily
Number of subjects: 98
Study 2093020 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine, 300 mg b.i.d.
Number of subjects: 98
Study 2093020 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole, 20 mg o.m.
Number of subjects: 98
Study 2093020 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine, 150 mg b.i.d.
Number of subjects: 98
Study 361056 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxapram hydrochloride (80 mg for females, 95 mg for males)
Number of subjects: 100
Study 361056 — intervention group
Group type: COMPARATOR
Intervention: Control (no doxapram)
Number of subjects: 100
Study 361056 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxapram hydrochloride
Number of subjects: 100
Study 30660721 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee arthroplasty (KA)
Number of subjects: 384
Study 27468823 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.0 mg betamethasone
Number of subjects: 70
Study 27468823 — intervention group
Group type: COMPARATOR
Intervention: 8 mg lornoxicam
Number of subjects: 70
Study 26521817 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard H pylori triple therapy (clarithromycin, metronidazole and lansoprazole)
Number of subjects: 134
Study 26521817 — intervention group
Group type: COMPARATOR
Intervention: Standard otitis media with effusion therapy (amoxicillin and clavulanate)
Number of subjects: 134
Study 26521817 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin and clavulanate (for H pylori stool antigen negative children)
Number of subjects: 134
Study 24445757 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 0
Study 22972873 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-ring isolation (SRI)
Number of subjects: 220
Study 22972873 — intervention group
Group type: COMPARATOR
Intervention: Wide antral isolation (WAI)
Number of subjects: 220
Study 22972873 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral isthmus line (MIL) ablation
Number of subjects: 220
Study 22972873 — intervention group
Group type: COMPARATOR
Intervention: No mitral isthmus line (MIL) ablation
Number of subjects: 220
Study 19638648 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytological surveillance
Number of subjects: 4201
Study 19638648 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral to colposcopy for biopsy and recall if necessary
Number of subjects: 4201
Study 19638648 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral to colposcopy with immediate treatment based on colposcopic appearance
Number of subjects: 4201
Study 19638648 — intervention group
Group type: COMPARATOR
Intervention: Immediate treatment
Number of subjects: 4201
Study 17289479 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol, 1.5 mg/kg IV
Number of subjects: 22
Study 17289479 — intervention group
Group type: COMPARATOR
Intervention: Nicardipine, 0.03 mg/kg IV
Number of subjects: 22
Study 15561991 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention schools
Number of subjects: 0
Study 15561991 — intervention group
Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 0
Study 12221343 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration exercise
Number of subjects: 60
Study 12221343 — intervention group
Group type: COMPARATOR
Intervention: Isodynamic lumbar extension exercise
Number of subjects: 60
Study 9925067 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg nebulized albuterol
Number of subjects: 160
Study 9925067 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg nebulized albuterol
Number of subjects: 160
Study 1653126 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercially available anticalculus dentifrice containing 5.0% soluble pyrophosphate in a 0.243% sodium fluoride silica base
Number of subjects: 0
Study 1653126 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercially available anticalculus dentifrice containing 1.3% soluble pyrophosphate and 1.5% of a Gantrez copolymer in a 0.243% sodium fluoride silica base
Number of subjects: 0
Study 1653126 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercially available anticalculus dentifrice containing 3.3% soluble pyrophosphate and 1.0% of a Gantrez copolymer in a 0.243% sodium fluoride silica base
Number of subjects: 0
Study 1653126 — intervention group
Group type: COMPARATOR
Intervention: Placebo dentifrice containing 0.243% sodium fluoride in a silica base
Number of subjects: 0
Study 6604469 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125 mg/kg diazepam
Number of subjects: 20
Study 6604469 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg diazepam
Number of subjects: 20
Study 6604469 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg diazepam
Number of subjects: 20
Study 6604469 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl only (control group)
Number of subjects: 20
Study 30633170 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 mg·kg rocuronium
Number of subjects: 120
Study 30633170 — intervention group
Group type: COMPARATOR
Intervention: 0.2 mg·kg cisatracurium
Number of subjects: 120
Study 28143739 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 × 10^7 cells
Number of subjects: 23
Study 28143739 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 × 10^7 cells
Number of subjects: 23
Study 26898856 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback intervention (letter from Chief Medical Officer and leaflet on antibiotics)
Number of subjects: 1581
Study 26898856 — intervention group
Group type: COMPARATOR
Intervention: Control (no communication)
Number of subjects: 1581
Study 26898856 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-focused intervention (patient-focused information promoting reduced use of antibiotics)
Number of subjects: 1581
Study 24652602 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher genetic ability to process alcohol
Number of subjects: 0
Study 24652602 — intervention group
Group type: EXPERIMENTAL
Intervention: Low genetic ability to process alcohol
Number of subjects: 0
Study 21841851 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Foundations (FF) intervention
Number of subjects: 178
Study 21841851 — intervention group
Group type: EXPERIMENTAL
Intervention: Sociodemographic variables (parent gender, socioeconomic status, age)
Number of subjects: 178
Study 21841851 — intervention group
Group type: EXPERIMENTAL
Intervention: Marital status
Number of subjects: 178
Study 20842169 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU)
Number of subjects: 66
Study 20842169 — intervention group
Group type: COMPARATOR
Intervention: Soy oil (control)
Number of subjects: 66
Study 18656083 — intervention group
Group type: EXPERIMENTAL
Intervention: PureVision lenses with biguanide-preserved solutions (ReNu MultiPlus, Complete MoisturePlus, AQuify)
Number of subjects: 0
Study 18656083 — intervention group
Group type: EXPERIMENTAL
Intervention: Opti‐Free Express, RepleniSH, Clear Care
Number of subjects: 0
Study 18656083 — intervention group
Group type: COMPARATOR
Intervention: Saline (Unisol 4 Preservative Free Saline)
Number of subjects: 0
Study 18656083 — intervention group
Group type: EXPERIMENTAL
Intervention: General observation
Number of subjects: 0
Study 16182828 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 205
Study 16182828 — intervention group
Group type: COMPARATOR
Intervention: CsA ME
Number of subjects: 205
Study 15320472 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil infusion during coronary reperfusion therapy
Number of subjects: 0
Study 15320472 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic treatment with Nicorandil
Number of subjects: 0
Study 10383583 — intervention group
Group type: EXPERIMENTAL
Intervention: Total pelvic exenteration (TPE)
Number of subjects: 50
Study 9097352 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 6
Study 9097352 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 8385478 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin
Number of subjects: 0
Study 3101154 — intervention group
Group type: EXPERIMENTAL
Intervention: Tidal volume increased (1 L to 1.5 L and 2 L)
Number of subjects: 12
Study 3101154 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing frequency increased (20, 30, 40 breaths/min)
Number of subjects: 12
Study 30104117 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR-RIT-Min
Number of subjects: 4516
Study 30104117 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR-RIT-Med
Number of subjects: 4516
Study 30104117 — intervention group
Group type: COMPARATOR
Intervention: MMR II
Number of subjects: 4516
Study 30104117 — intervention group
Group type: COMPARATOR
Intervention: MMR-RIT and MMR II
Number of subjects: 4516
Study 26264387 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified milk (1000 mg calcium for pre-M women and 1200 mg calcium for PM women, 96 mg magnesium, 2.4 mg zinc, 15 µg vitamin D, 4 g FOS-inulin per day)
Number of subjects: 257
Study 26264387 — intervention group
Group type: COMPARATOR
Intervention: Regular milk (500 mg calcium per day)
Number of subjects: 257
Study 26264387 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified milk
Number of subjects: 257
Study 26264387 — intervention group
Group type: COMPARATOR
Intervention: Regular milk
Number of subjects: 257
Study 26264387 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified milk and regular milk
Number of subjects: 257
Study 25153616 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation (FES) during gait training sessions (45-min, three times a week)
Number of subjects: 26
Study 25153616 — intervention group
Group type: COMPARATOR
Intervention: Sensory stimulation during gait training sessions (45-min, three times a week)
Number of subjects: 26
Study 23053255 — intervention group
Group type: EXPERIMENTAL
Intervention: dinaciclib + aprepitant
Number of subjects: 12
Study 23053255 — intervention group
Group type: COMPARATOR
Intervention: dinaciclib alone
Number of subjects: 12
Study 20360607 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based rehabilitation program (4 physical therapy sessions)
Number of subjects: 88
Study 20360607 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy-supervised rehabilitation program (17 physical therapy sessions)
Number of subjects: 88
Study 18802161 — intervention group
Group type: EXPERIMENTAL
Intervention: ADAPt‐C collaborative care management
Number of subjects: 472
Study 18802161 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 472
Study 16059590 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 15
Study 16059590 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromazepam
Number of subjects: 15
Study 11844944 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 0
Study 11844944 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 0
Study 10408548 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline NIHSS score
Number of subjects: 1281
Study 10408548 — intervention group
Group type: EXPERIMENTAL
Intervention: NIHSS scores of 7 to 10
Number of subjects: 1281
Study 10408548 — intervention group
Group type: EXPERIMENTAL
Intervention: NIHSS scores of 11 to 15
Number of subjects: 1281
Study 10408548 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacunar stroke (TOAST subtype)
Number of subjects: 1281
Study 7733040 — intervention group
Group type: EXPERIMENTAL
Intervention: 17.5 micrograms (700 IU) vitamin D/d
Number of subjects: 247